Download PDF
1 / Pages

Other users also viewed these articles

Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia Natalia Mena-Vázquez; Sara Manrique Arija; Marta Rojas-Giménez; Enrique Raya-ÿlvarez; María Luisa Velloso-Feijoó; C. López-Medina; Consuelo Ramos-Giraldez; Francisco Javier Godoy-Navarrete; Rocío Redondo-Rodríguez; Alba María Cabezas-Lucena; M. Morales-ÿguila; C.M. Romero-Barco; Antonio Fernández-Nebro;
Reumatol Clin. 2022;18:422-8
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection Montserrat Robustillo-Villarino; Laura Álvarez-Arroyo; Francisco Javier Carrera-Hueso; Inés Barreda-Altaba; María Nieto-Cid; Ana María Girona-Sanz; David El-Qutob;
Reumatol Clin. 2022;18:331-7